Lupin gains on receiving tentative approval for Generic Giazo Tablets

29 Dec 2016 Evaluate

Lupin is currently trading at Rs. 1460.00, up by 7.85 points or 0.54% from its previous closing of Rs 1452.15 on the BSE.

The scrip opened at Rs. 1456.00 and has touched a high and low of Rs 1465.10 and Rs 1452.20 respectively. So far 89159 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 1911.55 on 09-Feb-2016 and a 52 week low of Rs 1294.05 on 29-Mar-2016.

Last one week high and low of the scrip stood at Rs 1467.00 and Rs 1399.00 respectively. The current market cap of the company is Rs 65821.58 crore.

The promoters holding in the company stood at 46.74%, while Institutions and Non-Institutions held 41.85% and 11.41% respectively.

Pharma Major Lupin has received tentative approval for its Balasalazide Disodium Tablets, 1.1 gm from the United States Food and Drug Administration (USFDA) to market a generic version of Salix Pharmaceuticals Inc's Giazo Tablets, 1.1 gm. The filing is from company's Goa manufacturing facility. 

The company’s Balasalazide Disodium tablets 1.1 gm are the AB rated generic equivalent of Salix Pharmaceuticals Inc's Giazo Tablets, 1.1 gm. Balasalazide Disodium tablets are indicated for the treatment of mildly to moderately active ulcerative colitis in male patients 18 years of age and older. Giazo Tablets had US sales of $0.79 million as per IMS MAT September 2016.

Lupin is a pharmaceutical company and is engaged in formulation of drugs and active pharmaceutical ingredients (APIs), generics, biotechnology, novel drug discovery and development, drug delivery systems and specialty pharmaceuticals.

Lupin Share Price

1609.85 25.60 (1.62%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.20
Dr. Reddys Lab 5922.45
Cipla 1339.45
Zydus Lifesciences 983.05
Lupin 1609.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.